×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
APDN – applied dna sciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
APDN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
09:22 am
apdn
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA [Yahoo! Finance]
High
Report
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA [Yahoo! Finance]
12/18
09:00 am
apdn
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
High
Report
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
12/17
06:47 pm
apdn
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
12/17
04:19 pm
apdn
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines [Yahoo! Finance]
High
Report
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines [Yahoo! Finance]
12/17
04:05 pm
apdn
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Low
Report
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
12/16
10:11 am
apdn
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out [Yahoo! Finance]
High
Report
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out [Yahoo! Finance]
12/16
10:00 am
apdn
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
High
Report
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
10/30
07:15 am
apdn
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
High
Report
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
Date
Time
Symbol
Company Name
Action
%Chg
12/17/2024
04:05 pm
apdn
applied dna sciences, inc.
BEAT
Report
4.9%
applied dna sciences, inc.
8/8/2024
04:10 pm
apdn
applied dna sciences, inc.
BEAT
Report
-2.4%
applied dna sciences, inc.
5/10/2024
04:05 pm
apdn
applied dna sciences, inc.
MISS
Report
-10.7%
applied dna sciences, inc.
2/8/2024
04:05 pm
apdn
applied dna sciences, inc.
BEAT
Report
1.7%
applied dna sciences, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
04:40 pm
apdn
Form 10-K APPLIED DNA SCIENCES For: Sep 30
High
Report
Form 10-K APPLIED DNA SCIENCES For: Sep 30
12/17
04:11 pm
apdn
Form 8-K APPLIED DNA SCIENCES For: Dec 17
Medium
Report
Form 8-K APPLIED DNA SCIENCES For: Dec 17
12/10
04:04 pm
apdn
Form DEFA14A APPLIED DNA SCIENCES
Medium
Report
Form DEFA14A APPLIED DNA SCIENCES
12/10
04:01 pm
apdn
Form DEF 14A APPLIED DNA SCIENCES For: Jan 23
High
Report
Form DEF 14A APPLIED DNA SCIENCES For: Jan 23
11/14
05:47 pm
apdn
Form SC 13G APPLIED DNA SCIENCES Filed by: Anson Funds Management LP
Medium
Report
Form SC 13G APPLIED DNA SCIENCES Filed by: Anson Funds Management LP
11/14
05:02 pm
apdn
Form PRE 14A APPLIED DNA SCIENCES For: Nov 14
Medium
Report
Form PRE 14A APPLIED DNA SCIENCES For: Nov 14
11/13
04:16 pm
apdn
Form SC 13G/A APPLIED DNA SCIENCES Filed by: Grossman Bruce
Medium
Report
Form SC 13G/A APPLIED DNA SCIENCES Filed by: Grossman Bruce
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/12
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries
322.2%
3/18 Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models 63.8%
4/15 Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing 27.2%
3/2 Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed 25.1%
9/16 Form 4 APPLIED DNA SCIENCES For: Sep 12 Filed by: CATELL ROBERT B 20.6%
4/21 Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital 20.0%
10/16 Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance 12.7%
4/30 Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging 12.7%
11/25 Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform 12.4%
8/26 Form 4 APPLIED DNA SCIENCES For: Aug 22 Filed by: Hayward James A 10.2%
3/18 Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models 63.8%
4/15 Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing 27.2%
3/2 Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed 25.1%
9/16 Form 4 APPLIED DNA SCIENCES For: Sep 12 Filed by: CATELL ROBERT B 20.6%
4/21 Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital 20.0%
10/16 Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance 12.7%
4/30 Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging 12.7%
11/25 Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform 12.4%
8/26 Form 4 APPLIED DNA SCIENCES For: Aug 22 Filed by: Hayward James A 10.2%
TOP News Decliners
11/13
Form S-1MEF APPLIED DNA SCIENCES
-56.7%
3/19 Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection -31.3%
7/17 Form 8-K APPLIED DNA SCIENCES For: Jul 16 -26.4%
9/18 Form S-1 APPLIED DNA SCIENCES -25.8%
7/19 Form 4 APPLIED DNA SCIENCES For: Dec 21 Filed by: Montgomery William W -16.1%
11/8 Form 8-K APPLIED DNA SCIENCES For: Nov 07 -15.4%
9/24 Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season -14.7%
3/20 Form 4 APPLIED DNA SCIENCES For: Mar 19 Filed by: Montgomery William W -13.5%
8/5 Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement -11.5%
11/14 Form 3 APPLIED DNA SCIENCES For: Nov 07 Filed by: Anchin Scott L -11.4%
3/19 Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection -31.3%
7/17 Form 8-K APPLIED DNA SCIENCES For: Jul 16 -26.4%
9/18 Form S-1 APPLIED DNA SCIENCES -25.8%
7/19 Form 4 APPLIED DNA SCIENCES For: Dec 21 Filed by: Montgomery William W -16.1%
11/8 Form 8-K APPLIED DNA SCIENCES For: Nov 07 -15.4%
9/24 Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season -14.7%
3/20 Form 4 APPLIED DNA SCIENCES For: Mar 19 Filed by: Montgomery William W -13.5%
8/5 Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement -11.5%
11/14 Form 3 APPLIED DNA SCIENCES For: Nov 07 Filed by: Anchin Scott L -11.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: